Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

Therapeutics

Health Care

Biotechnology

Orum Therapeutics

SJ Lee

Susan B.

Peter U. Park

Olaf Christensen

Greg Dwyer

The Operations Team at Orum Therapeutics is responsible for ensuring the seamless execution of various projects and laboratory activities. This includes managing laboratory resources and workflows, overseeing clinical operations, and coordinating across different functional areas to support the development and delivery of innovative therapeutic antibodies. The team ensures operational efficiency and compliance with regulatory standards to advance the company's mission in targeting unmet medical needs in cancer and rare diseases.

Operations Team

Leadership Team

Scientific Research Team

Operations Team

About

Team members

Other teams at Orum Therapeutics

Leadership Team

Scientific Research Team